Clinical Trials Logo

Gastritis H Pylori clinical trials

View clinical trials related to Gastritis H Pylori.

Filter by:
  • None
  • Page 1

NCT ID: NCT06269380 Completed - Clinical trials for Intestinal Metaplasia

Evaluation of Antral Biopsies Obtained in Normal Esophagogastroduodenoscopy

Start date: February 13, 2024
Phase: N/A
Study type: Interventional

Esophagogastroduodenoscopy (EGD) is commonly performed in patients presenting with abdominal pain and dyspeptic symptoms, serving as a valuable diagnostic and therapeutic tool. While various methods are available for biopsy sampling when mucosal pathology is observed during EGD, the practice of obtaining biopsies from endoscopically normal mucosa remains controversial. Although there is literature suggesting that routine biopsies from the antrum and duodenum for surveillance purposes increase costs, pathological findings can sometimes be detected in areas that appear normal on mucosal examination, leading to potential changes in treatment approach if biopsies are obtained. In this study, a retrospective evaluation of the prevalence of various pathologies detected in biopsies obtained from endoscopically normal mucosa in patients who underwent EGD was reported as normal.

NCT ID: NCT06015763 Not yet recruiting - Gastritis H Pylori Clinical Trials

Correlation Between H.Pylori Colonization and Gastritis

Start date: October 2023
Phase: N/A
Study type: Interventional

To study the prevelance rate of H.pylori colonization in patients with gastritis. To correlate the H.pylori colonization with endoscopic finding. To correlate both H.pylori colonization and endoscopic finding with clinical manifestation.

NCT ID: NCT05101395 Completed - Gastritis Clinical Trials

Prevalence of H. Pylori Gastritis in Sleeve Gastrectomy Specimens

Start date: January 1, 2015
Phase:
Study type: Observational

This is a cross-sectional study looking for prevalence of H.Pylori related gastritis among patients underwent sleeve gastrectomy over five year study period. The study also looks for possible association with patients's characteristics. Also, compares its findings with similar regional and international studies.

NCT ID: NCT04769583 Completed - Gastritis H Pylori Clinical Trials

14-day Quadruple Therapy Versus Triple Therapy in HP Eradication

HEPRA
Start date: February 10, 2019
Phase: Phase 4
Study type: Interventional

In this prospective randomized-controlled study, treatment-naive H. pylori-infected patients are randomized to receive either standard triple therapy or sequential therapy. The aim is to compare the efficacy of concomitant quadruple therapy with standard triple therapy as a first line treatment for H. pylori infection in Tunisian patients.

NCT ID: NCT04652284 Not yet recruiting - Clinical trials for Helicobacter Infections

Effectiveness of Rifabutin for Treatment of Helicobacter Pylori

Start date: May 1, 2021
Phase: Phase 3
Study type: Interventional

The aim of this study is to determine the effectiveness of rifabutin triple therapy for the treatment of H. pylori infection in the Israeli population. Patients with or without a prior history of H. pylori eradication failure will be randomized to receive one of three possible treatments: Group 1-amoxicillin 1000mg bd and rifabutin 150 mg bd and esomeprazole 40 mg bd Group 2- amoxicillin 1000mg bd and rifabutin 150 mg d and esomeprazole 40 mg bd Group 3- standard of care

NCT ID: NCT04489030 Completed - Gastritis H Pylori Clinical Trials

Magnifying NBI Endoscopy for Gastric Condition

Start date: June 1, 2016
Phase:
Study type: Observational

Recently, the improved resolution with standard endoscopy allows the close observation of highly inflamed gastric mucosa without a magnifying view. In a previous study, the investigators established the endoscopic classification of H. pylori-infected stomach by non-magnifying standard endoscopy. One normal RAC pattern and three types of abnormal patterns were observed. Overall diagnostic accuracy for predicting H. pylori-infection was 91.6%. However, there is no comparison study predicting H. pylori-infection and precancerous gastric lesions between standard and magnifying endoscopy.